OptioRx

Osteoporosis is a silent disease of menopause.

When women and their providers discuss hormone replacement therapy, the focus is often on symptoms—hot flashes, sleep disruption, mood changes. These conversations typically happen around ages 45–50, the average timing of menopause.

But here’s what often gets missed:

By age 65—when insurance typically covers a DEXA scan—many women are only then learning they have osteopenia or osteoporosis. Sometimes, the first sign is a fracture.

What happened in the 20 years prior?

Between ages 45 and 65, estrogen levels decline significantly. Some women feel it. Some don’t.
But bone always does.

Estradiol plays a critical role in maintaining bone density, and bone loss accelerates rapidly in the first 3–5 years after menopause.

Translation: By the time we measure it, we may already be behind.

👉 This is your reminder to:

Ask about earlier bone density screening if you have risk factors
Have a proactive conversation about estrogen therapy and bone health
Think beyond symptoms—this is about long-term health and fracture prevention

Even if you don’t have hot flashes.

Learn more: www.optiorx.com

Not all “bioidentical” HRT is the same 🌸🧬
True personalization goes beyond labels—it’s about the right molecule, dose, and delivery. Precision care, powered by OptioRx 💊✨

Learn more: www.optiorx.com

PSA to women everywhere 📣🌸
HRT timing matters—and symptoms often start earlier than expected.
Supporting informed, personalized care with OptioRx 💊🧠✨

Learn more: www.optiorx.com